RxDoctor Payments DataLook up a doctor →

Stephanie Carson

Acute Care · Charleston, SCNPI 1609379288

Payments from drug & device makers

$8,529in general payments, 2019–2025

Across 393 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$505
  • AstraZeneca$478
  • Pfizer$467
  • Novartis$457
  • Lilly USA, LLC$388
  • Regeneron Healthcare Solutions, Inc.$326
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck20$505
AstraZeneca26$478
Pfizer25$467
Novartis20$457
Lilly USA, LLC16$388
Regeneron Healthcare Solutions, Inc.16$326
Takeda Pharmaceuticals U.S.A., Inc.12$316
Daiichi Sankyo Inc.12$308
Sanofi12$284
Jazz Pharmaceuticals Inc.13$249
Amgen11$227
Genentech USA, Inc.12$223
Eisai Inc.11$222
Bristol Myers Squibb11$220
Johnson & Johnson(2 entities)8$210
Gilead(2 entities)3$205
Incyte Corporation9$199
Acrotech Biopharma Inc.8$189
E.r. Squibb & Sons, L.L.C.10$187
Rigel Pharmaceuticals, Inc.7$167
Seagen Inc.8$153
ADC Therapeutics America, Inc.8$152
Taiho Oncology, Inc.7$137
Puma Biotechnology, Inc.7$136
GSK8$133
Astellas Pharma US Inc6$123
Beigene USA, Inc.6$120
AbbVie7$120
Boehringer Ingelheim4$118
Alnylam Pharmaceuticals Inc.5$115
Sobi, Inc4$85
Karyopharm Therapeutics Inc.4$83
Deciphera Pharmaceuticals Inc.3$72
Pharmaessentia USA Corporation2$64
Bayer3$63
BD1$63
Novocure Inc.2$59
Tersera Therapeutics LLC3$59
Kyowa Kirin, Inc.3$59
AVEO Pharmaceuticals, Inc.2$59
Stemline Therapeutics Inc.2$51
Pharmacyclics LLC, An Abbvie Company3$46
Azurity Pharmaceuticals, Inc.2$43
Genmab U.S., Inc.2$43
Shield Therapeutics Inc2$35
Morphosys, US Inc.2$33
EMD Serono, Inc.2$31
Array Biopharma Inc2$30
Ipsen Biopharmaceuticals, Inc2$30
EUSA Pharma (US) LLC1$27
G1 Therapeutics, Inc.1$25
Geron Corporation1$25
Mirati Therapeutics, Inc.1$24
Tolmar, Inc.1$23
Pharmaand GmbH1$23
Forte Bio-pharma LLC1$23
CSL Behring1$23
Medtronic1$21
Abiomed1$21
Exelixis Inc.1$19

How this compares

$8,529 in reported general payments places this provider in the 95th percentile of 339 acute care providers in South Carolina.

See all acute care providers in South Carolina →

Medicare billing

Part B allowed, 2024
$70,345
Medicare patients
357
Services billed
884

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Charleston

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →